Newsletter
Every new paper in this field, in your inbox.
Examining elderly gastric cancer patients (>75 years) in the U.S., this study, using propensity score matching, reveals that neoadjuvant chemotherapy (NAC) utilization increased from 2013 to 2019 (21% to 42.7%). After matching, 1958 patients showed that those receiving NAC experienced enhanced oncological outcomes following resection…
Examining esophagectomy outcomes for pathologic T3 esophageal cancer (n=519, 2000–2019), researchers categorized patients based on circumferential radial margin (CRM) involvement. CRM+ (tumor at CRM) correlated with shorter disease-free survival (DFS) and overall survival (OS) compared to CRM-. CRM-close (tumor >0 to 1 mm from CRM)…
Investigating hiatal hernia (HH) size reporting, researchers compared subjective estimates with objective axial length measurements in 93 patients. While endoscopic subjective size allocations correlated with intra-operative decisions, axial length measurements significantly correlated with manometry results. Only one barium swallow report included an objective HH size…
A European multicenter study comparing total (TG) and subtotal gastrectomy (SG) for antropyloric poorly cohesive carcinoma found no significant difference in 5-year overall survival (TG: 53.8%, SG: 53.0%) or disease-free survival (TG: 46.0%, SG: 45.3%). Despite similar baseline characteristics, TG showed higher postoperative complications. This…
Analyzing 34 cases with right aortic arch (RAA) or double aortic arch (DAA) and esophageal cancer, the study found that esophagectomy, whether via thoracotomy or thoracoscopic surgery, can be safely performed for both conditions. Patients, predominantly Japanese males with squamous cell carcinoma, commonly underwent left…
Examining 2013 publications, researchers spotlight the surge in gastric cancer immunotherapy research, with China dominating contributions. Keywords like "tumor microenvironment" and "adoptive immunotherapy" emerged as hotspots. Analysis of clinical trials underscores progress, emphasizing immune checkpoint inhibitors and chimeric antigen receptor T-cells as promising options. The…
In the realm of esophageal squamous cell carcinoma (ESCC), the battle between neoadjuvant chemotherapy (NAC) and adjuvant chemotherapy (AC) takes center stage. A squad of 684 ESCC patients engaged in this retrospective face-off at Henan Cancer Hospital. Post Propensity Score Matching (PSM), the NAC squad…
This study scrutinizes laparoscopic versus open surgery for peptic ulcer perforation (PUP). Analyzing 29 studies (17,228 patients), laparoscopy emerges as a superior choice. Laparoscopic intervention correlates with shorter hospital stays, reduced blood loss, and fewer complications. Remarkably, laparoscopy also exhibits a lower mortality rate. However,…
In the world of esophageal cancer surgery, a study from Karolinska University Hospital unveils CRP (C-reactive protein) as a superhero. Analyzing 612 patients, the research identifies a spike of ≥4.65% in CRP levels between postoperative days 2 to 3 as a signal for anastomotic leakage…
In the exploration of treatments for advanced esophageal squamous cell carcinoma (ESCC), researchers compared outcomes of neoadjuvant chemotherapy (NCT), neoadjuvant chemoradiotherapy (NCRT), and neoadjuvant immunochemotherapy (NICT). NCRT and NICT groups exhibited superior pathological responses, with higher pathologic complete response rates (29.9% and 23.6%, respectively) compared…
